“GLP-1 Receptor Agonist Drugs As a Protective Factor Against Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus”. Research, Society and Development, vol. 10, no. 16, Dec. 2021, p. e134101623517, https://doi.org/10.33448/rsd-v10i16.23517.